A study to evaluate the effectiveness of a drug combination in reducing respiratory tract infections in children aged 3 to 12 years.
Recruiting
Investigated Diseases:Investigated Drugs:
A study to evaluate the efficacy and safety of obinutuzumab compared to prednisolone in adults with newly onset minimal change disease
Recruiting
Investigated Diseases:Investigated Drugs:
A study of the safety and effectiveness of REGN17372 and linvoseltamab in adults with relapsed or refractory multiple myeloma
Recruiting
Investigated Diseases:Investigated Drugs:
powered by
